Blood-Based Genomic Profiling Of Cell-Free Dna (Cfdna) To Identify Microsatellite Instability (Msi-H), Tumor Mutational Burden (Tmb) And Wnt/B-Catenin Pathway Alterations In Patients With Gastrointestinal (Gi) Tract Cancers.